Oncopore: Phase I started

LTX-315 is in Phase I testing to treat solid tumors, while GV1001, a cancer vaccine targeting human telomerase reverse transcriptase (hTERT),

Read the full 217 word article

How to gain access

Continue reading with a
two-week free trial.